Associate Professor. Electrophysiologist with a special interest in device therapy for heart failure.

Joined December 2016
3 Photos and videos
Left ventricular lead position matters in Cardiac Resynchronization Therapy. Previously we showed that repositioning an unfavourably positioned LV lead was beneficial: ncbi.nlm.nih.gov/pmc/article… Here we show similar observational results in a larger cohort: onlinelibrary.wiley.com/doi/…
1
57
Rasmus Borgquist retweeted
12 Jan 2023
🚨Latest #OpenAccess Article in @JICE_EP Maximizing QRS duration Reduction in Contemporary CRT is feasible & Shorter QRS Duration is Associated with Better Clinical Outcomes by @RBorgquist @PlatonovPyotr & @david_mortsell ☕️📖 #OpenAccess: doi.org/10.1007/s10840-022-0… #EPeeps
6
15
2,060
Rasmus Borgquist retweeted
Repositioning and optimization of left ventricular lead position in nonresponders to cardiac resynchronization therapy is associated with improved ejection fraction, lower NT-proBNP values, and fewer heart failure symptoms heartrhythmopen.com/article/…
6
16
Rasmus Borgquist retweeted
Comprehensive review on CSP. You can get a free copy by clicking the link below for a limited time only [before 11/18]. Thank you @EPrystowskyonEP for the invitation. authors.elsevier.com/a/1dqDr… @psharmadoc @atulverma_md @DrRoderickTung @gauravaupadhyay @Hisdoc1 #EPeeps

17
57
Rasmus Borgquist retweeted
1
24
56
Images from the previous case
1
Right sided CRT upgrade in patient with laminopathy and huge (10x10cm) right atrium. Easy CS cannulation with Worley sheath handshaped Cordis MPB 1 guide and then amplatz wire for stability during PL lead placement - thank you @seth_j_worley for tips!
1
1
Rasmus Borgquist retweeted
The relentless @MdHuang presents his data on HBP/LBBAP in AVN ablation. *90% HBP success vs. 100% LBBAP ** Equivalent effect (none) on LVEF ***23 patients switched from HBP to LBBAP for LBBB ****Very low complication rate. #HRS2021 #EPeeps @EPeeps_Bot
1
7
16
Rasmus Borgquist retweeted
New in #JACCCEP: #LBBAP is a feasible & safe alternative for #CRT w/ low & stable thresholds w/ improved NYHA class & #echocardiogram outcomes. Read more about this multicenter, international study from @HisDoc1 & Marek_Jastrz_EP et al. here: bit.ly/2NcJn6T #ACCIntl
3
50
126
#EPeeps 75yr male, DCM, LBBB, Chronic AF, AVN ablated. Two previous suboptimal LV leads w exit-block, Wise-CRT impossible acoustic window in supine position. Amazing shortening of QRSd to 130ms with HBP postlat LV, after extraction of previous 4 leads. Case done w/ Dr. Mörtsell.
1
2
Rasmus Borgquist retweeted
New #PARADIGMHF analysis by Dr. Luis Rohde, @Nchatterjeemd, and @mvaduganathan shows #ARNI prevents sudden death in #HFrEF. Will optimal #GDMT implementation change who may ultimately require an #ICD? Find out here: bit.ly/360MnJ9
42
65
Rasmus Borgquist retweeted
28 Oct 2020
Just published @ScienceMagazine. >30,000 people w/mild to moderate #COVID19 have excellent IgG antibody titers for several months. No disappearing act. Important👍👍 science.sciencemag.org/conte… @MountSinaiNYC @FatimaAmanat @DrDavidReich @florian_krammer @IcahnMountSinai et al ,
18
408
1,218
Rasmus Borgquist retweeted
Excited for a great symposium this Saturday: #PPS4 Unfortunately not in Tampa, but the organization made a wise decision to go online with great sessions @DrRoderickTung @Hisdoc1 @KennethEllenbo1 @gopi_gdanda1
12
31
Rasmus Borgquist retweeted
14 Oct 2020
Some people thought Sweden's model was bad, reckless.
100
142
543
Rasmus Borgquist retweeted
For first time in its 208 years, the New England Journal of Medicine has endorsed a presidential candidate. It’s accompanying editorial is the best, most succinct examination I have read of the country’s leadership failure in the pandemic. nejm.org/doi/full/10.1056/NE…
14
114
293
Rasmus Borgquist retweeted
9 Sep 2020
1/NEW: Today the SPIRIT-AI and CONSORT-AI Working Group have published the first reporting guidelines for clinical trials evaluating AI interventions in @NatureMedicine @LancetDigitalH @bmj_latest
45
223
488
Rasmus Borgquist retweeted
Delighted to share our sudden death analysis in PARADIGM-HF @JACCJournals Paper: bit.ly/2FmDHTy Primary findings: 1) ⬆️global variation in prim prev ICD use 2) ICD ⬇️SCD ~56% (similar for ICM and NICM) 3) S/V ⬇️SCD ~20% ICD-eligible and ~50% in ICD pts
1
22
68